ASO Author Reflections: Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma

This is a preview of subscription content, log in to check access.


  1. 1.

    Amaria RN, Menzies AM, Burton EM, et al. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. Lancet Oncol. 2019;20(7):378–89.

    Article  Google Scholar 

  2. 2.

    Amaria RN, Reddy SM, Tawbi HA, et al. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018;24(11):1649–54.

    CAS  Article  Google Scholar 

  3. 3.

    Rozeman EA, Menzies AM, van Akkooi ACJ, et al. Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomized, controlled trial. Lancet Oncol. 2019;20(7):948–60.

    CAS  Article  Google Scholar 

  4. 4.

    Daud AI, Loo K, Pauli ML, et al. Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. J Clin Invest. 2016;126(9):3447–52.

    Article  Google Scholar 

  5. 5.

    Loo K, Tsai KK, Mahuron K, et al. Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy. JCI Insight. 2017;2(14): e93433.

    Article  Google Scholar 

  6. 6.

    Levine LS, Mahuron KM, Tsai KK, et al. Tumor immune profiling based neoadjuvant immunotherapy for locally advanced melanoma. Ann Surg Oncol. 2020.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Adil I. Daud MBBS.

Ethics declarations


Adil Daud - Research Funding from Novartis, Roche/Genentech, Pfizer, BMS, Merck, Checkmate, Incyte and OncoSec. Stock in Trex bio.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mahuron, K.M., Levine, L.S. & Daud, A.I. ASO Author Reflections: Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma. Ann Surg Oncol 27, 4131–4132 (2020).

Download citation